Rhinoorbitocerebral mucormycosis: A case report and literature review

被引:0
作者
Gonzalez Martin-Moro, Javier [1 ]
Lopez-Arcas Calleja, Jose Maria
Burgueno Garcia, Miguel
Cebrian Carretero, Jose Luis
Garcia Rodriguez, Julio [2 ]
机构
[1] Hosp Univ La Paz, Serv Cirugia Oral & Maxilofacial, Dept Oral & Maxillofacial Surg, Madrid 28046, Spain
[2] Hosp Univ La Paz, Dept Microbiol, Madrid 28046, Spain
来源
MEDICINA ORAL PATOLOGIA ORAL Y CIRUGIA BUCAL | 2008年 / 13卷 / 12期
关键词
Mucormycosis; diabetes; ketoacidosis; inmunosupression; paranasal sinuses; Amphotericine B; extended maxillectomy; Rhizopus oryzae;
D O I
暂无
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Mucormycosis is a rare oportunistic infection typically described in diabetic patients with a ketoacidotic status, as well as neutropenic patients. The infection is caused by a group of saprophytic fungi of the class Phycomicetes, being the most frequent ones the Rhizomucor, Rhizopus and Mucor. Its hystological findings include vascular trombosis and tissue necrosis, predominantly in the rino-orbito-cerebral area. Even though the frequency of presentation is very low, given its rapid evolution and severe consequences which include a high mortality rate, it is very important to be aware of the main features of the disease and treat it promptly. Although the diagnosis is based on the high clinical suspect, the computed tomography (CT) and the magnetic resonance image (MRI) plays an important role in determining the extension. The patients should receive treatment in a reference hospital so that a multidisciplinary approach is ensured. In this sense, we present a case of rhino-orbito-cerebralmucormycosis in a diabetic patient, recently treated in our Department. A comprehensive review of the literature has been performed to update the physiopathology and diagnosis. Finally, we describe the different treatment options focusing in the surgical approach, as well as the medical treatment with amphotericine and posaconzole
引用
收藏
页码:E792 / E795
页数:4
相关论文
共 15 条
  • [1] ABEDI E, 1984, LARYNGOSCOPE, V94, P1060, DOI 10.1288/00005537-198408000-00013
  • [2] RHINOCEREBRAL PHYCOMYCOSIS IN ASSOCIATION WITH DIABETIC KETOACIDOSIS - REPORT OF 2 CASES AND A REVIEW OF CLINICAL AND EXPERIMENTAL EXPERIENCE WITH AMPHOTERICIN B THERAPY
    ABRAMSON, E
    WILSON, D
    ARKY, RA
    [J]. ANNALS OF INTERNAL MEDICINE, 1967, 66 (04) : 735 - +
  • [3] Auluck Ajit, 2007, Med Oral Patol Oral Cir Bucal, V12, pE360
  • [4] Craniofacial zygomycosis caused by Apophysomyces elegans
    Chakrabarti, A
    Panda, N
    Varma, SC
    Singh, K
    Das, A
    Sharma, SC
    Padhye, AA
    [J]. MYCOSES, 1997, 40 (11-12) : 419 - 421
  • [5] In vitro susceptibilities of zygomycetes to conventional and new antifungals
    Dannaoui, E
    Meletiadis, J
    Mouton, JW
    Meis, JFGM
    Verweij, PE
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2003, 51 (01) : 45 - 52
  • [6] Survival after rhino-orbital-cerebral mucormycosis in an immunocompetent patient
    Fairley, C
    Sullivan, TJ
    Bartley, P
    Allworth, T
    Lewandowski, R
    [J]. OPHTHALMOLOGY, 2000, 107 (03) : 555 - 558
  • [7] FERRY AP, 1983, OPHTHALMOLOGY, V90, P1096, DOI 10.1016/S0161-6420(83)80052-9
  • [8] Rhino-orbitocerebral mucormycosis attributable to Apophysomyces elegans in an immunocompetent individual:: Case report and review of the literature
    Garcia-Covarrubias, L
    Bartlett, R
    Barratt, DM
    Wassermann, RJ
    [J]. JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE, 2001, 50 (02): : 353 - 357
  • [9] Posaconazole as salvage therapy for zygomycosis
    Greenberg, RN
    Mullane, K
    van Burik, JAH
    Raad, I
    Abzug, MJ
    Anstead, G
    Herbrecht, R
    Langston, A
    Marr, KA
    Schiller, G
    Schuster, M
    Wingard, JR
    Gonzalez, CE
    Revankar, SG
    Corcoran, G
    Kryscio, RJ
    Hare, R
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (01) : 126 - 133
  • [10] Rhino-orbitocerebral mucormycosis caused by Apophysomyces elegans
    Liang, KP
    Tleyjeh, IM
    Wilson, WR
    Roberts, GD
    Temesgen, Z
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2006, 44 (03) : 892 - 898